JSE Limited (JSE:JSE) News - Dealings in securities by a director and prescribed officers JSE LIMITED (Incorporated in the Republic of South Africa) Registration number: 2005/022939/06 Share Code: JSE ISIN Code: ZAE000079711 LEI: 213800MZ1VUQEBWRFO39 ("JSE") DEALINGS IN SECURITIES BY A DIRECTOR AND PRESCRIBED OFFICERS In accordance with the terms of the JSE’s long-term incentive scheme ("LTIS 2018"), share awards granted in 2018 have vested in the hands of executive committee members of the JSE, including an executive director and prescribed officers (the "Participants"). On instruction of the named Participants below, the JSE LTIS 2018 Trust sold 6 800 of these vested JSE ordinary shares ("LTIS 2018 shares") on 5 November 2021 in the open market at a selling price of 11300 cents per ordinary share with a total transaction value of R768 400. The transactions for each Participant were as follows: Name Role Number of Value of LTIS 2018 transaction shares sold A Takoordeen Executive Director 1 507 R170 291 A Greenwood Prescribed Officer 1 604 R181 252 M Randall Prescribed Officer 2 984 R337 192 V Reddy Prescribed Officer 705 R79 665 All interests are direct, beneficial and clearance to deal was granted by the Chairman of the Board. Sandton 10 November 2021 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 10-11-2021 02:05:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.